(As of 10/31/2024)

Pender Corporate Bond Fund Class A

(High Yield Fixed Income)
FundGrade A+® Rating recipient
For more information about FundGrade click here
2022
2021
2019
2018



Inception Return
(6/1/2009) 		5.94 %
YTD Return 12.73 %
NAVPS
(11/19/2024) 		$13.03
Change ($0.03) / -0.25 %
Growth of $10,000 (As of October 31, 2024)
MER 2.07 %
Assets ($mil) $2,030.63
Rank (1Yr) 15/302
Std Dev (3Yr) 8.74 %
Volatility Ranking (3Yr) 1/10
RRSP Eligibility Yes
Load Back Fee Only
Max Front End 5.00 %
Max Back End -
Sales Status Open
 
Objective
The objective of the Fund is to preserve capital and generate returns through current income and capital appreciation. The Fund invests primarily in investment and non-investment grade fixed income securities issued by North American corporations. This, however, does not preclude the Fund from making equity investments when the Manager deems the risk/reward trade-off to be in the investors’ favour.
Fund Manager

PenderFund Capital Management Ltd.

Portfolio Manager

Geoff Castle, PenderFund Capital Management Ltd.

Parul Garg, PenderFund Capital Management Ltd.

Emily Wheeler, PenderFund Capital Management Ltd.

Sub-Advisor
Data not available
 
Asset Allocation
(As of October 31, 2024)
Sector Allocation
(As of October 31, 2024)
Geographic Allocation
(As of October 31, 2024)
Top 10 Holdings
NameAssetSectorGeographicPercent
Lucid Group Inc 1.25% 15-Dec-2026Foreign BondsFixed IncomeUnited States2.62%
Esperion Therapeutics Inc 4.00% 15-Nov-2025Foreign BondsFixed IncomeUnited States2.59%
First Majestic Silver Corp 0.38% 15-Jan-2027Foreign BondsFixed IncomeUnited States2.34%
VeriSign, Inc 4.75% 29-Nov-2024Cash and EquivalentsCash and Cash EquivalentUnited States2.12%
Trulieve Cannabis Corp - PfdUS EquityConsumer GoodsUnited States2.01%
Rivian Holdings LLC 10.50% 15-Oct-2026Foreign BondsFixed IncomeUnited States1.91%
Canada Government 21-Nov-2024Cash and EquivalentsCash and Cash EquivalentCanada1.78%
Revance Therapeutics Inc 1.75% 15-Feb-2027Foreign BondsFixed IncomeUnited States1.68%
Emergent BioSolutions Inc 3.88% 15-Aug-2028Foreign BondsFixed IncomeUnited States1.63%
Waste Management Canada Corp 2.60% 23-Jul-2026Domestic BondsFixed IncomeCanada1.55%

Performance Data (As of October 31, 2024)
  Return (%) Annualized Return (%)
Return 1 Mth 3 Mth 6 Mth YTD 1 Yr 3 Yr 5 Yr 10 Yr
Fund 1.01 2.52 8.81 12.73 18.42 4.22 5.59 5.53
Benchmark 2.26 3.80 8.78 13.90 17.70 6.03 4.75 6.38
Quartile Ranking 1 1 1 1 1 1 1 1

Calendar Return (%) 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Fund 6.62 -6.56 9.37 6.23 4.74 5.54 7.01 22.69 -8.71 0.64
Benchmark 10.36 -6.92 0.50 6.14 7.98 5.36 2.96 10.80 14.93 8.91
Quartile Ranking 4 1 1 2 4 1 1 1 4 4

Website powered by © Fundata Canada Inc.
Mutual Fund Data provided by Fundata. | View Terms and Conditions of Use.
BofA Merill Lynch Indices used with permission.
© 2024 Fundata Canada Inc. All rights reserved. | View Privacy Policy | Contact Us.